Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Lifecore Biomedical
LFCR
$166M
| $5.07M | ﹤0.01% |
451,082
+28,122
| +7% | +$324K |
|
2902
AquaBounty Technologies
AQB
$4.73M
| $5.07M | ﹤0.01% |
47,301
+22,406
| +90% | +$2.57M |
|
|
SEI
2903
Solaris Energy Infrastructure
SEI
$3.39B
| $5.05M | ﹤0.01% |
518,804
+36,721
| +8% | +$389K |
|
|
CD
2904
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $5.05M | ﹤0.01% |
337,450
+312,551
| +1,255% | +$4.7M |
|
2905
Apyx Medical
APYX
$177M
| $5.05M | ﹤0.01% |
490,082
+115
| +0% | +$1.14K |
|
2906
Design Therapeutics
DSGN
$790M
| $5.03M | ﹤0.01% |
252,760
+215,060
| +570% | +$5.43M |
|
|
NVO
2907
Novo Nordisk
NVO
$209B
| $5.03M | ﹤0.01% |
119,998
+11,376
| +10% | +$441K |
|
|
NOTV
2908
DELISTED
Inotiv
NOTV
| $5.02M | ﹤0.01% |
188,284
+131,184
| +230% | +$3.29M |
|
|
LTRPA
2909
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $5.02M | ﹤0.01% |
1,233,067
+29,296
| +2% | +$142K |
|
2910
AST SpaceMobile
ASTS
$19.1B
| $5.01M | ﹤0.01% |
+387,044
| New | +$3.48M |
|
|
CBAY
2911
DELISTED
Cymabay Therapeutics
CBAY
| $4.99M | ﹤0.01% |
1,145,605
-11,369
| -1% | -$50.4K |
|
2912
Full House Resorts
FLL
$83.8M
| $4.99M | ﹤0.01% |
501,926
+305,984
| +156% | +$2.96M |
|
2913
Artesian Resources
ARTNA
$352M
| $4.98M | ﹤0.01% |
135,507
+11,603
| +9% | +$463K |
|
|
AMPE
2914
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $4.98M | ﹤0.01% |
9,937
+5,145
| +107% | +$2.76M |
|
|
ATHX
2915
DELISTED
Athersys, Inc. Common Stock
ATHX
| $4.97M | ﹤0.01% |
138,175
+15,639
| +13% | +$643K |
|
2916
908 Devices
MASS
$345M
| $4.97M | ﹤0.01% |
128,207
-582
| -0.5% | -$26.4K |
|
2917
MetroCity Bankshares
MCBS
$1.02B
| $4.96M | ﹤0.01% |
283,532
+37,093
| +15% | +$616K |
|
|
PRTK
2918
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.94M | ﹤0.01% |
724,407
+29,392
| +4% | +$238K |
|
2919
Mercer International
MERC
$44.4M
| $4.93M | ﹤0.01% |
386,993
-2,316
| -0.6% | -$34.3K |
|
2920
Future Fuel
FF
$215M
| $4.93M | ﹤0.01% |
513,888
-31,389
| -6% | -$379K |
|
2921
XBiotech
XBIT
$68M
| $4.93M | ﹤0.01% |
297,922
+24,684
| +9% | +$419K |
|
2922
Dianthus Therapeutics
DNTH
$5.73B
| $4.92M | ﹤0.01% |
31,449
+6,212
| +25% | +$1.14M |
|
2923
First Bancorp
FNLC
$400M
| $4.92M | ﹤0.01% |
166,952
+11,661
| +8% | +$348K |
|
|
SRTA
2924
Strata Critical Medical Inc
SRTA
$470M
| $4.91M | ﹤0.01% |
467,205
+452,099
| +2,993% | +$4.46M |
|
2925
Preformed Line Products
PLPC
$1.74B
| $4.9M | ﹤0.01% |
66,103
+2,112
| +3% | +$152K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.